Ultra-Processed Foods Raise Heart Disease Risk by Up to 65%, Major European Report Finds
A landmark European cardiology consensus links high UPF consumption to dramatically higher risks of heart disease, atrial fibrillation, and early death.
Summary
A major new report published in the European Heart Journal confirms that eating large amounts of ultra-processed foods significantly raises the risk of heart disease and early death. Combining findings from all available research on the topic, the European Society of Cardiology found that heavy UPF consumers face up to a 19% greater risk of heart disease, a 13% higher risk of atrial fibrillation, and a striking 65% higher risk of dying from cardiovascular disease. UPFs — industrially manufactured foods loaded with additives, sugar, salt, and unhealthy fats — also worsen obesity, type 2 diabetes, and high blood pressure. The authors are urging doctors to routinely ask patients about UPF intake and to push for clearer food labeling and updated dietary guidelines that go beyond nutrients to address food processing levels.
Detailed Summary
Ultra-processed foods have long been suspected of harming health, but a sweeping new consensus statement from the European Society of Cardiology puts the cardiovascular danger into sharp relief. Published in the European Heart Journal, the report synthesizes all currently available research linking UPF consumption to heart disease and death, making it one of the most comprehensive assessments of this dietary risk factor to date.
The findings are striking. Adults who eat the most ultra-processed foods face up to a 19% greater risk of developing heart disease, a 13% higher risk of atrial fibrillation, and as much as a 65% higher risk of dying from cardiovascular causes compared to those who eat the least. Beyond the heart, high UPF intake is strongly associated with obesity, type 2 diabetes, high blood pressure, and chronic kidney disease — a cluster of conditions that compound cardiovascular risk over time.
The mechanisms behind this damage are multiple. UPFs can disrupt metabolism, trigger systemic inflammation, and promote overconsumption even when labeled as healthy options. Their industrial ingredients and additives replace whole food components in ways that appear to undermine the body's normal regulatory systems. Notably, UPFs now account for 61% of calories consumed in the Netherlands and 54% in the UK, compared with just 18% in Italy, suggesting strong cultural and policy variation in exposure.
Lead researchers are calling for immediate changes in clinical practice. They want doctors caring for cardiovascular patients to routinely ask about UPF consumption as part of dietary assessments — a step not currently standard in most healthcare settings. They also advocate for updated national dietary guidelines that explicitly address food processing, not just nutrient content.
For health-conscious individuals, the practical implication is clear: reducing reliance on packaged and industrially manufactured foods in favor of minimally processed whole foods may meaningfully lower cardiovascular risk. The magnitude of the death risk increase — up to 65% — is a number that should motivate real dietary change.
Key Findings
- Heavy UPF consumers face up to 65% higher risk of cardiovascular death compared to low consumers.
- High UPF intake raises heart disease risk by 19% and atrial fibrillation risk by 13%.
- UPFs worsen obesity, type 2 diabetes, high blood pressure, and chronic kidney disease simultaneously.
- UPFs make up 61% of calories in the Netherlands and 54% in the UK, versus only 18% in Italy.
- European cardiologists now urge doctors to routinely assess UPF intake in all at-risk patients.
Methodology
This is a news report summarizing a clinical consensus statement published in the European Heart Journal by the European Society of Cardiology. The consensus aggregates findings from all currently available research on UPFs and cardiovascular outcomes, representing a high-level evidence synthesis. The source organizations are among the most credible in European cardiology, lending strong institutional weight to the conclusions.
Study Limitations
The article is a news summary and does not provide full access to the underlying primary studies or effect size confidence intervals. As a consensus statement rather than a single controlled trial, findings are observational in nature and causality cannot be definitively established. Readers should consult the full European Heart Journal publication and individual cited studies to assess methodology and confounding variables.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.